#1 out of 3
sports1d ago
MLB analysts raise alarm over Bo Bichette’s “red flags” behind Blue Jays' potential re-signing delay
Sportskeeda.com and 1 more
- Bo Bichette is being evaluated by the Blue Jays amid health red flags and a cautious re-signing stance in a volatile market.
- Health concerns, including prior injuries, factor into Bichette's value and the Jays' willingness to commit long-term.
- Bichette missed 81 games in 2024 due to knee, quad, and calf issues, complicating his price tag with the Jays.
- Recent contract dynamics, including Dylan Cease's seven-year, $210 million deal, shape the Jays' approach to Bichette's potential deal.
- Analysts expect CBA negotiations to encourage spending restraint on players with injury risk.
- Bichette remains a strong offensive asset (career .294 with 111 HR and 437 RBI), but health issues cloud his market value.
- The Red Sox have shown interest in Bichette as a potential upgrade, highlighting continued league buzz around his value.
- Bichette's positional versatility (shortstop, second, third) keeps him as a flexible option for potential buyers like Boston.
- Boston’s pursuit would depend on other moves, notably if Alex Bregman returns or not, framing Bichette as a Plan B.
- The Red Sox's interest underscores Bichette's stature as a sought-after middle-infield bat, even as the Jays weigh risk factors.
Vote 1


